The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis

Evidence for a two-stage disability progression in multiple sclerosis

(2010) E. Leray et al.   BRAIN

Functional Interactions between Endogenous Cannabinoid and Opioid Systems: Focus on Alcohol, Genetics and Drug-Addicted Behaviors

(2010) J. Lopez-Moreno et al.   CURRENT DRUG TARGETS

Modulation of Cannabinoid Receptor Activation as a Neuroprotective Strategy for EAE and Stroke

(2009) Ming Zhang et al.   Journal of Neuroimmune Pharmacology

Plasma endocannabinoid levels in multiple sclerosis

(2009) L. Jean-Gilles et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosis

(2009) Richard A Rudick et al.   LANCET NEUROLOGY

The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain

(2009) E. Ramil et al.   Multiple Sclerosis Journal

Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis

(2009) Silvia Rossi et al.   NEUROBIOLOGY OF DISEASE

Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis

(2009) Diego Centonze et al.   NEUROLOGICAL SCIENCES

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET

A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules

(2008) L. Mestre et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

Genetic deletion of Fatty Acid Amide Hydrolase results in improved long-term outcome in chronic autoimmune encephalitis

(2008) Michael Webb et al.   NEUROSCIENCE LETTERS

Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis

(2007) J. Ludovic Croxford et al.   JOURNAL OF NEUROIMMUNOLOGY